Valuation: Electromed, Inc.

Market Cap 35Cr 30Cr 28Cr 26Cr 49Cr 3.36TCr 50Cr 335.99Cr 132.15Cr 1.64TCr 130.91Cr 128.04Cr 5.66TCr P/E 2026 *
34.6x
P/E 2027 * 28.4x
Enterprise Value 35Cr 30Cr 28Cr 26Cr 49Cr 3.36TCr 50Cr 335.99Cr 132.15Cr 1.64TCr 130.91Cr 128.04Cr 5.66TCr EV / Sales 2026 *
4.74x
EV / Sales 2027 * 4.17x
Free-Float
82.82%
Yield 2026 *
-
Yield 2027 * -
1 day-1.64%
1 week-7.78%
Current month-0.47%
1 month+8.84%
3 months+61.55%
6 months+51.28%
Current year+44.57%
1 week 41.01
Extreme 41.01
47.38
1 month 37.5
Extreme 37.5001
47.4
Current year 23.01
Extreme 23.01
47.4
1 year 17.73
Extreme 17.73
47.4
3 years 8.8
Extreme 8.8
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 69 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Tax

Chief Financial Officer

-674 0.0081%
08/06/26 Fiscal year

Chief Executive Officer

29,100 0.3514%
04/06/26 Fiscal year

Chief Financial Officer

31,003 0.3744%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-7.78%+130.94%+276.90% 35Cr
-1.97%+1.03%+28.39%+1.68% 20TCr
-0.58%+2.40%+7.25%-15.35% 14TCr
-14.15%-15.08%-33.40%-2.68% 12TCr
-1.32%-1.65%-57.52%-16.63% 6.54TCr
-2.40%-7.03%+12.08%-6.81% 4.94TCr
-0.11%+1.53%-23.83%-30.51% 4.47TCr
-3.41%-2.11%+15.33%+9.95% 3.71TCr
-2.44%-1.98%+28.33%+35.71% 3.62TCr
-1.86%-2.39%-22.85%-10.01% 2.87TCr
Average -2.99%-2.86%+8.47%+24.23% 7.26TCr
Weighted average by Cap. -3.69%-1.84%-0.92%-4.85%

Financials

2026 *2027 *
Net sales 7.36Cr 6.43Cr 5.94Cr 5.47Cr 10Cr 708.78Cr 11Cr 71Cr 28Cr 347.13Cr 28Cr 27Cr 1.19TCr 8.36Cr 7.31Cr 6.74Cr 6.21Cr 12Cr 805.08Cr 12Cr 81Cr 32Cr 394.3Cr 31Cr 31Cr 1.36TCr
Net income 1.05Cr 92.05L 84.94L 78.3L 1.48Cr 101.44Cr 1.51Cr 10Cr 3.99Cr 50Cr 3.96Cr 3.87Cr 171.02Cr 1.28Cr 1.12Cr 1.03Cr 95.39L 1.8Cr 123.59Cr 1.84Cr 12Cr 4.87Cr 61Cr 4.82Cr 4.71Cr 208.37Cr
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
17/26/17 $42.10 -1.64% 3,18,239
16/26/16 $42.80 +1.21% 1,05,417
15/26/15 $42.29 -4.62% 1,04,895
14/26/14 $44.34 -3.59% 1,06,769
13/26/13 $45.99 +0.74% 97,395
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.10USD
Average target price
40.33USD
Spread / Average Target
-4.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock